 |
corticotropin-releasing factor receptor-1 antagonist containing an unfused thiazole ring |
|---|---|
| Trade Name | |
| Orphan Indication | Congenital adrenal hyperplasia |
| USA Market Approval | USA |
| USA Designation Date | 2017-11-08 00:00:00 |
| Sponsor | Spruce Biosciences;548 Market Street, Suite 74598;San Francisco, California, 94104 |
